Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (19212)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jun 8, 2016 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Hepatology
ISSN
1948-5182
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Kristiansen MNB, Veidal SS, Rigbolt KTG, Tølbøl KS, Roth JD, Jelsing J, Vrang N, Feigh M. Obese diet-induced mouse models of nonalcoholic steatohepatitis-tracking disease by liver biopsy. World J Hepatol 2016; 8(16): 673-684 [PMID: 27326314 DOI: 10.4254/wjh.v8.i16.673] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v8/i16/673.htm |
| Number | Citing Articles |
| 1 |
Christina-Maria Flessa, Narjes Nasiri-Ansari, Ioannis Kyrou, Bianca M. Leca, Maria Lianou, Antonios Chatzigeorgiou, Gregory Kaltsas, Eva Kassi, Harpal S. Randeva. Genetic and Diet-Induced Animal Models for Non-Alcoholic Fatty Liver Disease (NAFLD) Research. International Journal of Molecular Sciences 2022; 23(24): 15791 doi: 10.3390/ijms232415791
|
| 2 |
Henrik H. Hansen, Gitte Hansen, Thomas Secher, Michael Feigh, Sanne S. Veidal, Keld Fosgerau, Jacob Jelsing, Niels Vrang. Translational Research Methods in Diabetes, Obesity, and Nonalcoholic Fatty Liver Disease. 2019; : 369 doi: 10.1007/978-3-030-11748-1_14
|
| 3 |
Mark Colin Gissler, Nathaly Anto-Michel, Jan Pennig, Philipp Scherrer, Xiaowei Li, Timoteo Marchini, Katharina Pfeiffer, Carmen Härdtner, Tijani Abogunloko, Timothy Mwinyella, Lucia Sol Mitre, Lisa Spiga, Christoph Koentges, Christian Smolka, Dominik von Elverfeldt, Natalie Hoppe, Peter Stachon, Bianca Dufner, Timo Heidt, Sven Piepenburg, Ingo Hilgendorf, Jan-Inge Bjune, Simon N. Dankel, Gunnar Mellgren, Gabriel Seifert, Steffen U. Eisenhardt, Heiko Bugger, Constantin von zur Muhlen, Christoph Bode, Andreas Zirlik, Dennis Wolf, Florian Willecke. Genetic Deficiency of TRAF5 Promotes Adipose Tissue Inflammation and Aggravates Diet-Induced Obesity in Mice. Arteriosclerosis, Thrombosis, and Vascular Biology 2021; 41(10): 2563 doi: 10.1161/ATVBAHA.121.316677
|
| 4 |
Evangelia S. Makri, Konstantinos Xanthopoulos, Panagiotis Mavrommatis Parasidis, Eleftheria Makri, Spyros Pettas, Anastasia Tsingotjidou, Angeliki Cheva, Iris Ballaouri, Spyridon Gerou, Antonis Goulas, Stergios A. Polyzos. Partial validation of a six-month high-fat diet and fructose-glucose drink combination as a mouse model of nonalcoholic fatty liver disease. Endocrine 2024; 85(2): 704 doi: 10.1007/s12020-024-03769-5
|
| 5 |
Antonio Carlos Soares Pantaleão, Marcio Pinto de Castro, Krishynan Shanty Fernandes Meirelles Araujo, Carlos Frederico Ferreira Campos, André Luiz Alves da Silva, José Eduardo Ferreira Manso, João Carlos Machado. Ultrasound biomicroscopy for the assessment of early-stage nonalcoholic fatty liver disease induced in rats by a high-fat diet. Ultrasonography 2022; 41(4): 750 doi: 10.14366/usg.21182
|
| 6 |
Gabriela Svobodová, Michaela Šadibolová, Eva Velecká, Lucia Mráziková, Petra Vaculová, Petra Matoušková, Jaroslav Kuneš, Lenka Maletínská, Iva Boušová. Metabolic Dysfunction-Associated Steatotic Liver Disease Is Accompanied by Increased Activities of Superoxide Dismutase, Catalase, and Carbonyl Reductase 1 and Levels of miR-200b-3p in Mouse Models. Antioxidants 2024; 13(11): 1371 doi: 10.3390/antiox13111371
|
| 7 |
Michelle L Boland, Denise Oró, Kirstine S Tølbøl, Sebastian T Thrane, Jens Christian Nielsen, Taylor S Cohen, David E Tabor, Fiona Fernandes, Andrey Tovchigrechko, Sanne S Veidal, Paul Warrener, Bret R Sellman, Jacob Jelsing, Michael Feigh, Niels Vrang, James L Trevaskis, Henrik H Hansen. Towards a standard diet-induced and biopsy-confirmed mouse model of non-alcoholic steatohepatitis: Impact of dietary fat source. World Journal of Gastroenterology 2019; 25(33): 4904-4920 doi: 10.3748/wjg.v25.i33.4904
|
| 8 |
Maria Nicoline Baandrup Kristiansen, Sanne Skovgård Veidal, Christina Christoffersen, Michael Feigh, Niels Vrang, Jonathan David Roth, Mary Erickson, Luciano Adorini, Jacob Jelsing. Validity of biopsy-based drug effects in a diet-induced obese mouse model of biopsy-confirmed NASH. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1149-z
|
| 9 |
Ines C.M. Simoes, Justyna Janikiewicz, Judith Bauer, Agnieszka Karkucinska-Wieckowska, Piotr Kalinowski, Agnieszka Dobrzyń, Andrzej Wolski, Maciej Pronicki, Krzysztof Zieniewicz, Paweł Dobrzyń, Marcin Krawczyk, Hans Zischka, Mariusz R. Wieckowski, Yaiza Potes. Fat and Sugar—A Dangerous Duet. A Comparative Review on Metabolic Remodeling in Rodent Models of Nonalcoholic Fatty Liver Disease. Nutrients 2019; 11(12): 2871 doi: 10.3390/nu11122871
|
| 10 |
Catherine M. Sampson, Andrea L. Dimet, Harshini Neelakantan, Kehinde O. Ogunseye, Heather L. Stevenson, Jonathan D. Hommel, Stanley J. Watowich. Combined nicotinamide N-methyltransferase inhibition and reduced-calorie diet normalizes body composition and enhances metabolic benefits in obese mice. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-85051-6
|
| 11 |
Andrea Ferrigno, Marta Cagna, Oriana Bosco, Michelangelo Trucchi, Clarissa Berardo, Ferdinando Nicoletti, Mariapia Vairetti, Laura G. Di Pasqua. MPEP Attenuates Intrahepatic Fat Accumulation in Obese Mice. International Journal of Molecular Sciences 2023; 24(7): 6076 doi: 10.3390/ijms24076076
|
| 12 |
Michelle L. Boland, Rhianna C. Laker, Karly Mather, Arkadiusz Nawrocki, Stephanie Oldham, Brandon B. Boland, Hilary Lewis, James Conway, Jacqueline Naylor, Silvia Guionaud, Michael Feigh, Sanne S. Veidal, Louise Lantier, Owen P. McGuinness, Joseph Grimsby, Cristina M. Rondinone, Lutz Jermutus, Martin R. Larsen, James L. Trevaskis, Christopher J. Rhodes. Resolution of NASH and hepatic fibrosis by the GLP-1R and GCGR dual-agonist cotadutide via modulating mitochondrial function and lipogenesis. Nature Metabolism 2020; 2(5): 413 doi: 10.1038/s42255-020-0209-6
|
| 13 |
Philipp Kasper, Saida Breuer, Thorben Hoffmann, Christina Vohlen, Ruth Janoschek, Lisa Schmitz, Sarah Appel, Gregor Fink, Christoph Hünseler, Alexander Quaas, Münevver Demir, Sonja Lang, Hans-Michael Steffen, Anna Martin, Christoph Schramm, Martin Bürger, Esther Mahabir, Tobias Goeser, Jörg Dötsch, Eva Hucklenbruch-Rother, Inga Bae-Gartz. Maternal Exercise Mediates Hepatic Metabolic Programming via Activation of AMPK-PGC1α Axis in the Offspring of Obese Mothers. Cells 2021; 10(5): 1247 doi: 10.3390/cells10051247
|
| 14 |
Davide Povero, Milos Lazic, Christopher McBride, Geza Ambrus-Aikelin, Ryan Stansfield, Casey D. Johnson, Angelina M. Santini, Rama F. Pranadinata, Matthew D. McGeough, Jeffrey A. Stafford, Hal M. Hoffman, Ariel E. Feldstein, James M. Veal, Gretchen Bain. Pharmacology of a Potent and Novel Inhibitor of the NOD-Like Receptor Pyrin Domain-Containing Protein 3 (NLRP3) Inflammasome that Attenuates Development of Nonalcoholic Steatohepatitis and Liver Fibrosis. Journal of Pharmacology and Experimental Therapeutics 2023; 386(2): 242 doi: 10.1124/jpet.123.001639
|
| 15 |
Naomichi Abe, Sayuka Kato, Takuma Tsuchida, Kanami Sugimoto, Ryuta Saito, Lars Verschuren, Robert Kleemann, Kozo Oka. Longitudinal characterization of diet-induced genetic murine models of nonalcoholic steatohepatitis with metabolic, histological, and transcriptomic hallmarks of human patients. Biology Open 2019; doi: 10.1242/bio.041251
|
| 16 |
David H Ipsen, Jens Lykkesfeldt, Pernille Tveden-Nyborg. Animal Models of Fibrosis in Nonalcoholic Steatohepatitis: Do They Reflect Human Disease?. Advances in Nutrition 2020; 11(6): 1696 doi: 10.1093/advances/nmaa081
|
| 17 |
Henrik H. Hansen, Susanne Pors, Maja W. Andersen, Mogens Vyberg, Jacob Nøhr-Meldgaard, Malte Hasle Nielsen, Denise Oró, Martin Rønn Madsen, Monika Lewinska, Mathias B. Møllerhøj, Andreas Nygaard Madsen, Michael Feigh. Semaglutide reduces tumor burden in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH-HCC with advanced fibrosis. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-50328-5
|
| 18 |
João Pedroso, João Camporez, Luciana Belpiede, Rafaela Pinto, José Cipolla-Neto, Jose Donato. Evaluation of Hepatic Steatosis in Rodents by Time-Domain Nuclear Magnetic Resonance. Diagnostics 2019; 9(4): 198 doi: 10.3390/diagnostics9040198
|
| 19 |
Jamie Bates, Archana Vijayakumar, Sarani Ghoshal, Bruno Marchand, Saili Yi, Dmytro Kornyeyev, Anna Zagorska, David Hollenback, Katie Walker, Kathy Liu, Swetha Pendem, David Newstrom, Robert Brockett, Igor Mikaelian, Saritha Kusam, Ricardo Ramirez, David Lopez, Li Li, Bryan C. Fuchs, David G. Breckenridge. Acetyl-CoA carboxylase inhibition disrupts metabolic reprogramming during hepatic stellate cell activation. Journal of Hepatology 2020; 73(4): 896 doi: 10.1016/j.jhep.2020.04.037
|
| 20 |
Jashdeep Bhattacharjee, Graham Beaton, Satheesh B. Ravula, Suk Joong Lee, Kevin B. Bacon, Celia P. Jenkinson, Mikako Warren, Fabio C. Tucci, Rohit Kohli. Lysophosphatidic acid receptor 1 antagonist (EPGN2154) causes regression of NASH in preclinical NASH models. Hepatology Communications 2023; 7(12) doi: 10.1097/HC9.0000000000000323
|
| 21 |
Feryal Savari, Seyyed Ali Mard, Mohammad Badavi, Anahita Rezaie, Mohammad Kazem Gharib-Naseri. A new method to induce nonalcoholic steatohepatitis (NASH) in mice. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-1041-x
|
| 22 |
Yvonne Oligschlaeger, Ronit Shiri-Sverdlov. NAFLD Preclinical Models: More than a Handful, Less of a Concern?. Biomedicines 2020; 8(2): 28 doi: 10.3390/biomedicines8020028
|
| 23 |
Oren Tirosh, Anna M. Giudetti. Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression. Oxidative Medicine and Cellular Longevity 2018; 2018(1) doi: 10.1155/2018/2548154
|
| 24 |
John J. Nestor, David Parkes, Michael Feigh, John J. Suschak, M. Scott Harris. Effects of ALT-801, a GLP-1 and glucagon receptor dual agonist, in a translational mouse model of non-alcoholic steatohepatitis. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-10577-2
|
| 25 |
Panyisha Wu, Moya Zhang, Nicholas J. G. Webster. Alternative RNA Splicing in Fatty Liver Disease. Frontiers in Endocrinology 2021; 12 doi: 10.3389/fendo.2021.613213
|
| 26 |
Takuma Tsuchida, Youngmin A. Lee, Naoto Fujiwara, Maria Ybanez, Brittany Allen, Sebastiao Martins, M. Isabel Fiel, Nicolas Goossens, Hsin-I. Chou, Yujin Hoshida, Scott L. Friedman. A simple diet- and chemical-induced murine NASH model with rapid progression of steatohepatitis, fibrosis and liver cancer. Journal of Hepatology 2018; 69(2): 385 doi: 10.1016/j.jhep.2018.03.011
|
| 27 |
Priyankar Dey. The role of gut microbiome in chemical-induced metabolic and toxicological murine disease models. Life Sciences 2020; 258: 118172 doi: 10.1016/j.lfs.2020.118172
|
| 28 |
Mathias B. Møllerhøj, Sanne S. Veidal, Kirstine Tølbøl Thrane, Denise Oró, Agnete Overgaard, Casper Gravesen Salinas, Martin Rønn Madsen, Larissa Pfisterer, Mogens Vyberg, Eric Simon, Andre Broermann, Niels Vrang, Jacob Jelsing, Michael Feigh, Henrik H. Hansen. Hepatoprotective effects of semaglutide, lanifibranor and dietary intervention in the GAN diet‐induced obese and biopsy‐confirmed mouse model of NASH. Clinical and Translational Science 2022; 15(5): 1167 doi: 10.1111/cts.13235
|
| 29 |
Jonathan D Roth, Michael Feigh, Sanne S Veidal, Louise KD Fensholdt, Kristoffer T Rigbolt, Henrik H Hansen, Li C Chen, Mathieu Petitjean, Weslyn Friley, Niels Vrang, Jacob Jelsing, Mark Young. INT-767 improves histopathological features in a diet-induced <i>ob/ob</i> mouse model of biopsy-confirmed non-alcoholic steatohepatitis. World Journal of Gastroenterology 2018; 24(2): 195-210 doi: 10.3748/wjg.v24.i2.195
|
| 30 |
Kyung Eun Kim, Jaewoong Lee, Hyun Joo Shin, Eun Ae Jeong, Hye Min Jang, Yu Jeong Ahn, Hyeong Seok An, Jong Youl Lee, Meong Cheol Shin, Soo Kyoung Kim, Won Gi Yoo, Won Ho Kim, Gu Seob Roh. Lipocalin‐2 activates hepatic stellate cells and promotes nonalcoholic steatohepatitis in high‐fat diet–fed Ob/Ob mice. Hepatology 2023; 77(3): 888 doi: 10.1002/hep.32569
|
| 31 |
Klaus Seedorf, Csaba Weber, Cedric Vinson, Sylvie Berger, Laurent-Michel Vuillard, Arpad Kiss, Stephanie Creusot, Olivier Broux, Anne Geant, Catherine Ilic, Karine Lemaitre, Johann Richard, Adel Hammoutene, Julien Mahieux, Virginie Martiny, Didier Durand, Fabien Melchiore, Miklos Nyerges, Valerie Paradis, Nicolas Provost, Valérie Duvivier, Philippe Delerive. Selective disruption of NRF2-KEAP1 interaction leads to NASH resolution and reduction of liver fibrosis in mice. JHEP Reports 2023; 5(4): 100651 doi: 10.1016/j.jhepr.2022.100651
|
| 32 |
Amandine Everard, Hubert Plovier, Marialetizia Rastelli, Matthias Van Hul, Alice de Wouters d’Oplinter, Lucie Geurts, Céline Druart, Sylvie Robine, Nathalie M. Delzenne, Giulio G. Muccioli, Willem M. de Vos, Serge Luquet, Nicolas Flamand, Vincenzo Di Marzo, Patrice D. Cani. Intestinal epithelial N-acylphosphatidylethanolamine phospholipase D links dietary fat to metabolic adaptations in obesity and steatosis. Nature Communications 2019; 10(1) doi: 10.1038/s41467-018-08051-7
|
| 33 |
Kandy T Velázquez, Reilly T Enos, Jackie E Bader, Alexander T Sougiannis, Meredith S Carson, Ioulia Chatzistamou, James A Carson, Prakash S Nagarkatti, Mitzi Nagarkatti, E Angela Murphy. Prolonged high-fat-diet feeding promotes non-alcoholic fatty liver disease and alters gut microbiota in mice. World Journal of Hepatology 2019; 11(8): 619-637 doi: 10.4254/wjh.v11.i8.619
|
| 34 |
Inga Bae-Gartz, Philipp Kasper, Nora Großmann, Saida Breuer, Ruth Janoschek, Tobias Kretschmer, Sarah Appel, Lisa Schmitz, Christina Vohlen, Alexander Quaas, Michal R. Schweiger, Christina Grimm, Axel Fischer, Nina Ferrari, Christine Graf, Christian K. Frese, Sonja Lang, Münevver Demir, Christoph Schramm, Gregor Fink, Tobias Goeser, Jörg Dötsch, Eva Hucklenbruch-Rother. Maternal exercise conveys protection against NAFLD in the offspring via hepatic metabolic programming. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-72022-6
|
| 35 |
Susanna Canali, Alexander W. Fischer, Mychael Nguyen, Karl Anderson, Lorna Wu, Anne-Renee Graham, Chiaowen Joyce Hsiao, Chinmayi Bankar, Nancy Dussault, Veronica Ritchie, Meagan Goodridge, Todd Sparrow, Allison Pannoni, Sze-Wah Tse, Vivienne Woo, Kaitlin Klovdahl, Jared Iacovelli, Eric Huang. Lipid-encapsulated mRNA encoding an extended serum half-life interleukin-22 ameliorates metabolic disease in mice. Molecular Metabolism 2024; 86: 101965 doi: 10.1016/j.molmet.2024.101965
|
| 36 |
Taesik Gwag, Eric Ma, Changcheng Zhou, Shuxia Wang. Anti‐CD47 antibody treatment attenuates liver inflammation and fibrosis in experimental non‐alcoholic steatohepatitis models. Liver International 2022; 42(4): 829 doi: 10.1111/liv.15182
|
| 37 |
Jie Liu, Bingyi Yao, Liangcai Gao, Yuanjin Zhang, Shengbo Huang, Xin Wang. Emerging role of carboxylesterases in nonalcoholic fatty liver disease. Biochemical Pharmacology 2022; 205: 115250 doi: 10.1016/j.bcp.2022.115250
|
| 38 |
Manuel Baader, Tom Bretschneider, Andre Broermann, Joerg F Rippmann, Birgit Stierstorfer, Christian A Kuttruff, Michael Mark. Characterization of the properties of a selective, orally bioavailable autotaxin inhibitor in preclinical models of advanced stages of liver fibrosis. British Journal of Pharmacology 2018; 175(4): 693 doi: 10.1111/bph.14118
|
| 39 |
Malte P. Suppli, Kristoffer T. G. Rigbolt, Sanne S. Veidal, Sara Heebøll, Peter Lykke Eriksen, Mia Demant, Jonatan I. Bagger, Jens Christian Nielsen, Denise Oró, Sebastian W. Thrane, Asger Lund, Charlotte Strandberg, Merete J. Kønig, Tina Vilsbøll, Niels Vrang, Karen L. Thomsen, Henning Grønbæk, Jacob Jelsing, Henrik H. Hansen, Filip K. Knop. Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals. American Journal of Physiology-Gastrointestinal and Liver Physiology 2019; 316(4): G462 doi: 10.1152/ajpgi.00358.2018
|
| 40 |
Xiaobo Wang, Mark R. Sommerfeld, Kerstin Jahn‐Hofmann, Bishuang Cai, Aveline Filliol, Helen E. Remotti, Robert F. Schwabe, Aimo Kannt, Ira Tabas. A Therapeutic Silencing RNA Targeting Hepatocyte TAZ Prevents and Reverses Fibrosis in Nonalcoholic Steatohepatitis in Mice. Hepatology Communications 2019; 3(9): 1221 doi: 10.1002/hep4.1405
|
| 41 |
S. Gómez-Zorita, I. Milton-Laskibar, M. T. Macarulla, L. Biasutto, A. Fernández-Quintela, J. Miranda, A. Lasa, N. Segues, L. Bujanda, M. P. Portillo. Pterostilbene modifies triglyceride metabolism in hepatic steatosis induced by high-fat high-fructose feeding: a comparison with its analog resveratrol. Food & Function 2021; 12(7): 3266 doi: 10.1039/D0FO03320K
|
| 42 |
Michael Landowski, Vijesh J. Bhute, Samuel Grindel, Zachary Haugstad, Yeboah K. Gyening, Madison Tytanic, Richard S. Brush, Lucas J. Moyer, David W. Nelson, Christopher R. Davis, Chi-Liang Eric Yen, Sakae Ikeda, Martin-Paul Agbaga, Akihiro Ikeda. Transmembrane protein 135 regulates lipid homeostasis through its role in peroxisomal DHA metabolism. Communications Biology 2023; 6(1) doi: 10.1038/s42003-022-04404-7
|
| 43 |
Yoshihisa Takahashi, Erdenetsogt Dungubat, Hiroyuki Kusano, Toshio Fukusato. Basic Protocols in Foods and Nutrition. Methods and Protocols in Food Science 2022; : 53 doi: 10.1007/978-1-0716-2345-9_4
|
| 44 |
Mathias Flensted-Jensen, Denise Oró, Emma A. Rørbeck, Chen Zhang, Martin Rønn Madsen, Andreas Nygaard Madsen, Jenny Norlin, Michael Feigh, Steen Larsen, Henrik H. Hansen. Dietary intervention reverses molecular markers of hepatocellular senescence in the GAN diet-induced obese and biopsy-confirmed mouse model of NASH. BMC Gastroenterology 2024; 24(1) doi: 10.1186/s12876-024-03141-x
|
| 45 |
L. Kořínková, V. Pražienková, L. Černá, A. Karnošová, B. Železná, J. Kuneš, Lenka Maletínská. Pathophysiology of NAFLD and NASH in Experimental Models: The Role of Food Intake Regulating Peptides. Frontiers in Endocrinology 2020; 11 doi: 10.3389/fendo.2020.597583
|
| 46 |
Aimo Kannt, Efstathia Papada, Claire Kammermeier, Giuseppe D'Auria, Nuria Jiménez‐Hernández, Martin Stephan, Uwe Schwahn, Andreas Nygaard Madsen, Mette Viberg Østergaard, George Dedoussis, M. Pilar Francino. Mastiha (Pistacia lentiscus) Improves Gut Microbiota Diversity, Hepatic Steatosis, and Disease Activity in a Biopsy‐Confirmed Mouse Model of Advanced Non‐Alcoholic Steatohepatitis and Fibrosis. Molecular Nutrition & Food Research 2019; 63(24) doi: 10.1002/mnfr.201900927
|
| 47 |
Anurag Mishra, Tamara R. Castañeda, Erik Bader, Bettina Elshorst, Sheila Cummings, Petra Scherer, Dinesh S. Bangari, Claudia Loewe, Herman Schreuder, Christoph Pöverlein, Mike Helms, Seth Jones, Gernot Zech, Thomas Licher, Michael Wagner, Manfred Schudok, Meltsje de Hoop, Alleyn T. Plowright, Jens Atzrodt, Aimo Kannt, Iina Laitinen, Volker Derdau. Triantennary GalNAc Molecular Imaging Probes for Monitoring Hepatocyte Function in a Rat Model of Nonalcoholic Steatohepatitis. Advanced Science 2020; 7(24) doi: 10.1002/advs.202002997
|
| 48 |
Agnieszka Karkucinska‐Wieckowska, Ines C. M. Simoes, Piotr Kalinowski, Magdalena Lebiedzinska‐Arciszewska, Krzysztof Zieniewicz, Piotr Milkiewicz, Magdalena Górska‐Ponikowska, Paolo Pinton, Afshan N. Malik, Marcin Krawczyk, Paulo J. Oliveira, Mariusz R. Wieckowski. Mitochondria, oxidative stress and nonalcoholic fatty liver disease: A complex relationship. European Journal of Clinical Investigation 2022; 52(3) doi: 10.1111/eci.13622
|
| 49 |
Malte Hasle Nielsen, Matthew P. Gillum, Niels Vrang, Jacob Jelsing, Henrik H. Hansen, Michael Feigh, Denise Oró. Hepatoprotective effects of the long-acting fibroblast growth factor 21 analog PF-05231023 in the GAN diet-induced obese and biopsy-confirmed mouse model of nonalcoholic steatohepatitis. American Journal of Physiology-Gastrointestinal and Liver Physiology 2023; 324(5): G378 doi: 10.1152/ajpgi.00157.2022
|
| 50 |
Henrik H. Hansen, Helene M. Ægidius, Denise Oró, Simon S. Evers, Sara Heebøll, Peter Lykke Eriksen, Karen Louise Thomsen, Anja Bengtsson, Sanne S. Veidal, Michel Feigh, Malte P. Suppli, Filip K. Knop, Henning Grønbæk, Diego Miranda, James L. Trevaskis, Niels Vrang, Jacob Jelsing, Kristoffer T. G. Rigbolt. Human translatability of the GAN diet-induced obese mouse model of non-alcoholic steatohepatitis. BMC Gastroenterology 2020; 20(1) doi: 10.1186/s12876-020-01356-2
|
| 51 |
Nikolaos Perakakis, Aditya Joshi, Natia Peradze, Konstantinos Stefanakis, Georgia Li, Michael Feigh, Sanne Skovgard Veidal, Glenn Rosen, Michael Fleming, Christos S. Mantzoros. The Selective Peroxisome Proliferator‐Activated Receptor Gamma Modulator CHS‐131 Improves Liver Histopathology and Metabolism in a Mouse Model of Obesity and Nonalcoholic Steatohepatitis. Hepatology Communications 2020; 4(9): 1302 doi: 10.1002/hep4.1558
|
| 52 |
Dominika Stygar, Tomasz Sawczyn, Agnieszka Dulska, Elżbieta Chełmecka, Łukasz Mielańczyk, Natalia Matysiak, Michał Kukla, Maciej Idzik, Jan Augustyniak, Andrzej Gabriel, Konrad Karcz, Jerzy Jochem. Ileal transposition helps to regulate plasma hepatokine levels in obese Zucker (Crl:ZUC(ORL)-Leprfa) rats. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-87293-w
|
| 53 |
F. Anthony Romero, Christopher T. Jones, Yingzi Xu, Martijn Fenaux, Randall L. Halcomb. The Race to Bash NASH: Emerging Targets and Drug Development in a Complex Liver Disease. Journal of Medicinal Chemistry 2020; 63(10): 5031 doi: 10.1021/acs.jmedchem.9b01701
|
| 54 |
Yeon Ji Chae, Dae Won Jun, Waqar Khalid Saeed, Hyeon Tae Kang, Ju Hee Oh, Seung Min Lee, Kiseok Jang. Feasibility and Stability of Liver Biopsy before Treatment for Preclinical Nonalcoholic Fatty Liver Studies. Journal of Korean Medical Science 2019; 34(2) doi: 10.3346/jkms.2019.34.e14
|
| 55 |
Antonella Vetuschi, Alfredo Cappariello, Paolo Onori, Eugenio Gaudio, Giovanni Latella, Simona Pompili, Roberta Sferra. Ferroptosis resistance cooperates with cellular senescence in the overt stage of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. European Journal of Histochemistry 2022; 66(3) doi: 10.4081/ejh.2022.3391
|
| 56 |
Adeline Bertola. Rodent models of fatty liver diseases. Liver Research 2018; 2(1): 3 doi: 10.1016/j.livres.2018.03.001
|
| 57 |
Peter Lykke Eriksen, Hendrik Vilstrup, Kristoffer Rigbolt, Malte P. Suppli, Michael Sørensen, Sara Heebøll, Sanne S. Veidal, Fillip K. Knop, Karen Louise Thomsen. Non‐alcoholic fatty liver disease alters expression of genes governing hepatic nitrogen conversion. Liver International 2019; 39(11): 2094 doi: 10.1111/liv.14205
|
| 58 |
Lucia Sessa, Simona Concilio, Jesús Fominaya, Daniela Eletto, Stefano Piotto, Xavier Busquets. A new serotonin 2A receptor antagonist with potential benefits in Non-Alcoholic Fatty Liver Disease. Life Sciences 2023; 314: 121315 doi: 10.1016/j.lfs.2022.121315
|
| 59 |
Bader Zarrouki, Jeremie Boucher. Kupffer Cells. Methods in Molecular Biology 2020; 2164: 121 doi: 10.1007/978-1-0716-0704-6_13
|
| 60 |
Waranya Chatuphonprasert, Yollada Sriset, Kanokwan Jarukamjorn. Continuous Consumption of Reused Palm Oil Induced Hepatic Injury, Depletion of Glutathione Stores, and Modulation of Cytochrome P450 Profiles in Mice. Polish Journal of Food and Nutrition Sciences 2019; 69(1): 53 doi: 10.31883/pjfns-2019-0009
|
| 61 |
Sridhar Radhakrishnan, Steven F Yeung, Jia-Yu Ke, Maísa M Antunes, Michael A Pellizzon. Considerations When Choosing High-Fat, High-Fructose, and High-Cholesterol Diets to Induce Experimental Nonalcoholic Fatty Liver Disease in Laboratory Animal Models. Current Developments in Nutrition 2021; 5(12): nzab138 doi: 10.1093/cdn/nzab138
|
| 62 |
Hannah Zhang, Mélissa Léveillé, Emilie Courty, Aysim Gunes, Bich N. Nguyen, Jennifer L. Estall. Differences in metabolic and liver pathobiology induced by two dietary mouse models of nonalcoholic fatty liver disease. American Journal of Physiology-Endocrinology and Metabolism 2020; 319(5): E863 doi: 10.1152/ajpendo.00321.2020
|
| 63 |
Diego Almanza, Mehrnaz Gharaee-Kermani, Alisa Zhilin-Roth, Jose A. Rodriguez-Nieves, Cory Colaneri, Todd Riley, Jill A. Macoska. Nonalcoholic Fatty Liver Disease Demonstrates a Pre-fibrotic and Premalignant Molecular Signature. Digestive Diseases and Sciences 2019; 64(5): 1257 doi: 10.1007/s10620-018-5398-4
|
| 64 |
Chisa Tometsuka, Noriko Funato, Kazunori Mizuno, Yuki Taga. Long-term intake of ginger protease-degraded collagen hydrolysate reduces blood lipid levels and adipocyte size in mice. Current Research in Food Science 2021; 4: 175 doi: 10.1016/j.crfs.2021.03.003
|
| 65 |
Jonathan D. Roth, Sanne S. Veidal, Louise K. D. Fensholdt, Kristoffer T. G. Rigbolt, Romeo Papazyan, Jens Christian Nielsen, Michael Feigh, Niels Vrang, Mark Young, Jacob Jelsing, Luciano Adorini, Henrik H. Hansen. Combined obeticholic acid and elafibranor treatment promotes additive liver histological improvements in a diet-induced ob/ob mouse model of biopsy-confirmed NASH. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-45178-z
|
| 66 |
Akihisa Nakamura, Koji Yamamoto, Rei Takeda, Ren Yamada, Akinori Kubo, Kenichi Morikawa, Sayaka Ando, Tomoe Shimazaki, Takaaki Izumi, Machiko Umemura, Takashi Kitagataya, Taku Shigesawa, Kazuharu Suzuki, Megumi Kimura, Masato Nakai, Takuya Sho, Goki Suda, Mitsuteru Natsuizaka, Koji Ogawa, Shunsuke Ohnishi, Toshiro Sugiyama, Hiroshi Takeda, Naoya Sakamoto. The potential of soluble CD14 in discriminating nonalcoholic steatohepatitis from nonalcoholic fatty liver disease. Hepatology Research 2022; 52(6): 508 doi: 10.1111/hepr.13757
|
| 67 |
Laura A. Barnes, Yinuo Xu, Ana Sanchez-Azofra, Esteban A. Moya, Michelle P. Zhang, Laura E. Crotty Alexander, Atul Malhotra, Omar Mesarwi. Duration of intermittent hypoxia impacts metabolic outcomes and severity of murine NAFLD. Frontiers in Sleep 2023; 2 doi: 10.3389/frsle.2023.1215944
|
| 68 |
Luciano Adorini, Kristoffer Rigbolt, Michael Feigh, Jonathan Roth, Mary Erickson, Matias A. Avila. Increased hepatoprotective effects of the novel farnesoid X receptor agonist INT-787 versus obeticholic acid in a mouse model of nonalcoholic steatohepatitis. PLOS ONE 2024; 19(4): e0300809 doi: 10.1371/journal.pone.0300809
|
| 69 |
Helene M. Ægidius, Sanne S. Veidal, Michael Feigh, Philip Hallenborg, Michele Puglia, Tune H. Pers, Niels Vrang, Jacob Jelsing, Birgitte R. Kornum, Blagoy Blagoev, Kristoffer T. G. Rigbolt. Multi-omics characterization of a diet-induced obese model of non-alcoholic steatohepatitis. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-58059-7
|
| 70 |
Jing Fang, Séverine Celton-Morizur, Chantal Desdouets. NAFLD-Related HCC: Focus on the Latest Relevant Preclinical Models. Cancers 2023; 15(14): 3723 doi: 10.3390/cancers15143723
|
| 71 |
Mikhaïl Van Herck, Luisa Vonghia, Sven Francque. Animal Models of Nonalcoholic Fatty Liver Disease—A Starter’s Guide. Nutrients 2017; 9(10): 1072 doi: 10.3390/nu9101072
|
| 72 |
Adeline Bertola. WITHDRAWN: Rodent models of fatty liver diseases. Liver Research 2018; doi: 10.1016/j.livres.2018.02.005
|
| 73 |
Daniel Veyel, Kathrin Wenger, Andre Broermann, Tom Bretschneider, Andreas H. Luippold, Bartlomiej Krawczyk, Wolfgang Rist, Eric Simon. Biomarker discovery for chronic liver diseases by multi-omics – a preclinical case study. Scientific Reports 2020; 10(1) doi: 10.1038/s41598-020-58030-6
|
| 74 |
Kirstine S Tølbøl, Maria NB Kristiansen, Henrik H Hansen, Sanne S Veidal, Kristoffer TG Rigbolt, Matthew P Gillum, Jacob Jelsing, Niels Vrang, Michael Feigh. Metabolic and hepatic effects of liraglutide, obeticholic acid and elafibranor in diet-induced obese mouse models of biopsy-confirmed nonalcoholic steatohepatitis. World Journal of Gastroenterology 2018; 24(2): 179-194 doi: 10.3748/wjg.v24.i2.179
|
| 75 |
Mahak Arora, Nikolina Kutinová Canová, Hassan Farghali. mTOR as an eligible molecular target for possible pharmacological treatment of nonalcoholic steatohepatitis. European Journal of Pharmacology 2022; 921: 174857 doi: 10.1016/j.ejphar.2022.174857
|
| 76 |
Gao Sun, Charles V. Jackson, Karen Zimmerman, Li-Kun Zhang, Courtney M. Finnearty, George E. Sandusky, Guodong Zhang, Richard G. Peterson, Yi-Xin (Jim) Wang. The FATZO mouse, a next generation model of type 2 diabetes, develops NAFLD and NASH when fed a Western diet supplemented with fructose. BMC Gastroenterology 2019; 19(1) doi: 10.1186/s12876-019-0958-4
|
| 77 |
Aimo Kannt, Paulus Wohlfart, Andreas Nygaard Madsen, Sanne Skovgård Veidal, Michael Feigh, Dieter Schmoll. Activation of thyroid hormone receptor‐β improved disease activity and metabolism independent of body weight in a mouse model of non‐alcoholic steatohepatitis and fibrosis. British Journal of Pharmacology 2021; 178(12): 2412 doi: 10.1111/bph.15427
|
| 78 |
Barbara Sinigaglia, Jorge Escudero, Simone A Biagini, Jorge Garcia-Calleja, Josep Moreno, Begoña Dobon, Sandra Acosta, Mayukh Mondal, Sandra Walsh, Gabriela Aguileta, Mònica Vallès, Stephen Forrow, Juan Martin-Caballero, Andrea Bamberg Migliano, Jaume Bertranpetit, Francisco J Muñoz, Elena Bosch, Brandon Gaut. Exploring Adaptive Phenotypes for the Human Calcium-Sensing Receptor Polymorphism R990G. Molecular Biology and Evolution 2024; 41(2) doi: 10.1093/molbev/msae015
|
| 79 |
Kikumi Ono-Moore, Matthew Ferguson, Michael Blackburn, Hassan Issafras, Sean Adams. Application of an In Vivo Hepatic Triacylglycerol Production Method in the Setting of a High-Fat Diet in Mice. Nutrients 2016; 9(1): 16 doi: 10.3390/nu9010016
|
| 80 |
Geurt Stokman, Anita M. van den Hoek, Ditte Denker Thorbekk, Elsbet J. Pieterman, Sanne Skovgård Veidal, Brittany Basta, Marta Iruarrizaga‐Lejarreta, José W. van der Hoorn, Lars Verschuren, Jimmy F. P. Berbée, Patrick C. N. Rensen, Tore Skjæret, Cristina Alonso, Michael Feigh, John J. P. Kastelein, Scott L. Friedman, Hans M. G. Princen, David A. Fraser. Dual targeting of hepatic fibrosis and atherogenesis by icosabutate, an engineered eicosapentaenoic acid derivative. Liver International 2020; 40(11): 2860 doi: 10.1111/liv.14643
|
| 81 |
Liang Dai, Qian Wang, Pengfei Wang, Shangran Zhang, Luyang Tai, Xiangrui Xu, Gang Sun, Mengyu Duan, Haoliang Yuan, Zhiqi Feng. Discovery of novel AdipoRon analogues as potent anti-inflammatory agents against nonalcoholic steatohepatitis. European Journal of Medicinal Chemistry 2022; 244: 114800 doi: 10.1016/j.ejmech.2022.114800
|
| 82 |
Seung-Ho Lee, Hansu Park, Eun-Kyoung Yang, Bo Ram Lee, Il-Hoon Jung, Tae-Hyoung Kim, Moon Jung Goo, Yuna Chae, Mi-Kyung Kim. GPR119 activation by DA-1241 alleviates hepatic and systemic inflammation in MASH mice through inhibition of NFκB signaling. Biomedicine & Pharmacotherapy 2023; 166: 115345 doi: 10.1016/j.biopha.2023.115345
|
| 83 |
Wenhua Shao, Mayuko Ichimura-Shimizu, Hirohisa Ogawa, Shengjian Jin, Mitsuko Sutoh, Satoko Nakamura, Miki Onodera, Hirosuke Tawara, Shunji Toyohara, Ryoji Hokao, Yasusei Kudo, Takeshi Oya, Koichi Tsuneyama. Establishment of repeated liver biopsy technique in experimental mice. Heliyon 2023; 9(6): e16978 doi: 10.1016/j.heliyon.2023.e16978
|
| 84 |
Henrik H. Hansen, Michael Feigh, Sanne S. Veidal, Kristoffer T. Rigbolt, Niels Vrang, Keld Fosgerau. Mouse models of nonalcoholic steatohepatitis in preclinical drug development. Drug Discovery Today 2017; 22(11): 1707 doi: 10.1016/j.drudis.2017.06.007
|
| 85 |
Aimo Kannt, Andreas Nygaard Madsen, Claire Kammermeier, Ralf Elvert, Tim Klöckener, Martin Bossart, Torsten Haack, Andreas Evers, Katrin Lorenz, Wolfgang Hennerici, Corinne Rocher, Zsolt Böcskei, Jean‐Claude Guillemot, Vincent Mikol, Francois Pattou, Bart Staels, Michael Wagner. Incretin combination therapy for the treatment of non‐alcoholic steatohepatitis. Diabetes, Obesity and Metabolism 2020; 22(8): 1328 doi: 10.1111/dom.14035
|
| 86 |
Sridhar Radhakrishnan, Jia-Yu Ke, Michael A Pellizzon. Targeted Nutrient Modifications in Purified Diets Differentially Affect Nonalcoholic Fatty Liver Disease and Metabolic Disease Development in Rodent Models. Current Developments in Nutrition 2020; 4(6): nzaa078 doi: 10.1093/cdn/nzaa078
|
| 87 |
Hieu Huy Phung, Chang Hoon Lee. Mouse models of nonalcoholic steatohepatitis and their application to new drug development. Archives of Pharmacal Research 2022; 45(11): 761 doi: 10.1007/s12272-022-01410-5
|
| 88 |
Dieter Schmoll, Nicole Ziegler, Benoit Viollet, Marc Foretz, Patrick C. Even, Dalila Azzout‐Marniche, Andreas Nygaard Madsen, Martin Illemann, Karen Mandrup, Michael Feigh, Jörg Czech, Heiner Glombik, Jacob A. Olsen, Wolfgang Hennerici, Klaus Steinmeyer, Ralf Elvert, Tamara R. Castañeda, Aimo Kannt. Activation of Adenosine Monophosphate—Activated Protein Kinase Reduces the Onset of Diet‐Induced Hepatocellular Carcinoma in Mice. Hepatology Communications 2020; 4(7): 1056 doi: 10.1002/hep4.1508
|
| 89 |
Helmut Denk, Peter M. Abuja, Kurt Zatloukal. Animal models of NAFLD from the pathologist's point of view. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2019; 1865(5): 929 doi: 10.1016/j.bbadis.2018.04.024
|
| 90 |
Kirstine S. Tølbøl, Birgit Stierstorfer, Jörg F. Rippmann, Sanne S. Veidal, Kristoffer T. G. Rigbolt, Tanja Schönberger, Matthew P. Gillum, Henrik H. Hansen, Niels Vrang, Jacob Jelsing, Michael Feigh, Andre Broermann. Disease Progression and Pharmacological Intervention in a Nutrient-Deficient Rat Model of Nonalcoholic Steatohepatitis. Digestive Diseases and Sciences 2019; 64(5): 1238 doi: 10.1007/s10620-018-5395-7
|
| 91 |
Saki Yoshimura, Yuki Tomiga, Shihoko Nakashima, Ai Ito, Shotaro Kawakami, Hiroaki Tanaka, Yoshinari Uehara, Yasuki Higaki. Effects of voluntary exercise training on liver fat accumulation - Measurement of over time CT imaging -. Japanese Journal of Physical Fitness and Sports Medicine 2017; 66(4): 283 doi: 10.7600/jspfsm.66.283
|
| 92 |
Bader Alabdulaali, Fatema Al-rashed, Mohammed Al-Onaizi, Anwar Kandari, Joanna Razafiarison, Dorothy Tonui, Michayla R. Williams, Camille Blériot, Rasheed Ahmad, Fawaz Alzaid. Macrophages and the development and progression of non-alcoholic fatty liver disease. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1195699
|
| 93 |
Daniel Jahn, Stefan Kircher, Heike M. Hermanns, Andreas Geier. Animal models of NAFLD from a hepatologist's point of view. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2019; 1865(5): 943 doi: 10.1016/j.bbadis.2018.06.023
|
| 94 |
Michelle L Boland, Stephanie Oldham, Brandon B Boland, Sarah Will, Jean-Martin Lapointe, Silvia Guionaud, Christopher J Rhodes, James L Trevaskis. Nonalcoholic steatohepatitis severity is defined by a failure in compensatory antioxidant capacity in the setting of mitochondrial dysfunction. World Journal of Gastroenterology 2018; 24(16): 1748-1765 doi: 10.3748/wjg.v24.i16.1748
|
| 95 |
Pascale Gluais‐Dagorn, Marc Foretz, Gregory R. Steinberg, Battsetseg Batchuluun, Anna Zawistowska‐Deniziak, Joost M. Lambooij, Bruno Guigas, David Carling, Pierre‐Axel Monternier, David E. Moller, Sebastien Bolze, Sophie Hallakou‐Bozec. Direct AMPK Activation Corrects NASH in Rodents Through Metabolic Effects and Direct Action on Inflammation and Fibrogenesis. Hepatology Communications 2022; 6(1): 101 doi: 10.1002/hep4.1799
|
| 96 |
Ahmad Salhab, Johnny Amer, Yinying Lu, Rifaat Safadi. Sodium+/taurocholate cotransporting polypeptide as target therapy for liver fibrosis. Gut 2022; 71(7): 1373 doi: 10.1136/gutjnl-2020-323345
|
| 97 |
Victoria S. Jensen, Pernille Tveden-Nyborg, Christina Zacho-Rasmussen, Michelle L. Quaade, David H. Ipsen, Henning Hvid, Christian Fledelius, Erik M. Wulff, Jens Lykkesfeldt. Variation in diagnostic NAFLD/NASH read-outs in paired liver samples from rodent models. Journal of Pharmacological and Toxicological Methods 2020; 101: 106651 doi: 10.1016/j.vascn.2019.106651
|
| 98 |
Juliane I. Beier, Valentina Medici, Sean Spencer, Weiguo Fan, Natalie J. Török. Metabolic Steatotic Liver Disease. 2024; : 41 doi: 10.1016/B978-0-323-99649-5.00006-6
|
| 99 |
Sebastian Martinez-Lopez, Enrique Angel-Gomis, Elisabet Sanchez-Ardid, Alberto Pastor-Campos, Joanna Picó, Isabel Gomez-Hurtado. The 3Rs in Experimental Liver Disease. Animals 2023; 13(14): 2357 doi: 10.3390/ani13142357
|
| 100 |
Yuanjun Guo, Zhengyu Gao, Edward L. LaGory, Lewis Wilson Kristin, Jamila Gupte, Yan Gong, Matthew J. Rardin, Tongyu Liu, Thong T. Nguyen, Jason Long, Yi-Hsiang Hsu, Justin K. Murray, Julie Lade, Simon Jackson, Jun Zhang. Liver-specific mitochondrial amidoxime–reducing component 1 (Mtarc1) knockdown protects the liver from diet-induced MASH in multiple mouse models. Hepatology Communications 2024; 8(5) doi: 10.1097/HC9.0000000000000419
|
| 101 |
Beatriz Carmona-Hidalgo, Isabel González-Mariscal, Adela García-Martín, María E. Prados, Francisco Ruiz-Pino, Giovanni Appendino, Manuel Tena-Sempere, Eduardo Muñoz. Δ9-Tetrahydrocannabinolic Acid markedly alleviates liver fibrosis and inflammation in mice. Phytomedicine 2021; 81: 153426 doi: 10.1016/j.phymed.2020.153426
|
| 102 |
Yun-Jung Choi, Jeff D. Johnson, Jin-Ju Lee, Jiangao Song, Marcy Matthews, Marc K. Hellerstein, Charles A. McWherter. Seladelpar combined with complementary therapies improves fibrosis, inflammation, and liver injury in a mouse model of nonalcoholic steatohepatitis. American Journal of Physiology-Gastrointestinal and Liver Physiology 2024; 326(2): G120 doi: 10.1152/ajpgi.00158.2023
|